BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32038783)

  • 1. Novel Dioxygenases, HIF-α Specific Prolyl-hydroxylase and Asparanginyl-hydroxylase: O
    Park H
    Toxicol Res; 2008 Jun; 24(2):101-107. PubMed ID: 32038783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Hydroxylation by Hypoxia-Inducible Factor (HIF) Hydroxylases: Unique or Ubiquitous?
    Strowitzki MJ; Cummins EP; Taylor CT
    Cells; 2019 Apr; 8(5):. PubMed ID: 31035491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases.
    Chan MC; Ilott NE; Schödel J; Sims D; Tumber A; Lippl K; Mole DR; Pugh CW; Ratcliffe PJ; Ponting CP; Schofield CJ
    J Biol Chem; 2016 Sep; 291(39):20661-73. PubMed ID: 27502280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic Investigations of the Role of Factor Inhibiting Hypoxia-inducible Factor (FIH) as an Oxygen Sensor.
    Tarhonskaya H; Hardy AP; Howe EA; Loik ND; Kramer HB; McCullagh JS; Schofield CJ; Flashman E
    J Biol Chem; 2015 Aug; 290(32):19726-42. PubMed ID: 26112411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
    Flashman E; Davies SL; Yeoh KK; Schofield CJ
    Biochem J; 2010 Mar; 427(1):135-42. PubMed ID: 20055761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the Oxygen-Sensing Asparaginyl Hydroxylase Factor Inhibiting Hypoxia-Inducible Factor: A Potential Hypoxia Response Modulating Strategy.
    Wu Y; Li Z; McDonough MA; Schofield CJ; Zhang X
    J Med Chem; 2021 Jun; 64(11):7189-7209. PubMed ID: 34029087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH).
    Cockman ME; Lancaster DE; Stolze IP; Hewitson KS; McDonough MA; Coleman ML; Coles CH; Yu X; Hay RT; Ley SC; Pugh CW; Oldham NJ; Masson N; Schofield CJ; Ratcliffe PJ
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14767-72. PubMed ID: 17003112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-dependent sequestration of an oxygen sensor by a widespread structural motif can shape the hypoxic response--a predictive kinetic model.
    Schmierer B; Novák B; Schofield CJ
    BMC Syst Biol; 2010 Oct; 4():139. PubMed ID: 20955552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of HIF: asparaginyl hydroxylation.
    Peet D; Linke S
    Novartis Found Symp; 2006; 272():37-49; discussion 49-53, 131-40. PubMed ID: 16686428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical characterization of human HIF hydroxylases using HIF protein substrates that contain all three hydroxylation sites.
    Pappalardi MB; McNulty DE; Martin JD; Fisher KE; Jiang Y; Burns MC; Zhao H; Ho T; Sweitzer S; Schwartz B; Annan RS; Copeland RA; Tummino PJ; Luo L
    Biochem J; 2011 Jun; 436(2):363-9. PubMed ID: 21410436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
    Hewitson KS; Schofield CJ; Ratcliffe PJ
    Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemistry of the hypoxia-inducible factor hydroxylases.
    Fiorini G; Schofield CJ
    Curr Opin Chem Biol; 2024 Apr; 79():102428. PubMed ID: 38330792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-prolyl hydroxylases and cardiovascular diseases.
    Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
    Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of dimerization and substrate phosphorylation inhibit factor inhibiting hypoxia-inducible factor (FIH) activity.
    Lancaster DE; McNeill LA; McDonough MA; Aplin RT; Hewitson KS; Pugh CW; Ratcliffe PJ; Schofield CJ
    Biochem J; 2004 Nov; 383(Pt. 3):429-37. PubMed ID: 15239670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen-sensing under the influence of nitric oxide.
    Berchner-Pfannschmidt U; Tug S; Kirsch M; Fandrey J
    Cell Signal; 2010 Mar; 22(3):349-56. PubMed ID: 19861159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the Hypoxic Response.
    Pugh CW
    Adv Exp Med Biol; 2016; 903():259-71. PubMed ID: 27343102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of novel monoclonal antibodies to determine the expression and distribution of the hypoxia regulatory factors PHD-1, PHD-2, PHD-3 and FIH in normal and neoplastic human tissues.
    Soilleux EJ; Turley H; Tian YM; Pugh CW; Gatter KC; Harris AL
    Histopathology; 2005 Dec; 47(6):602-10. PubMed ID: 16324198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferritin heavy chain controls the HIF-driven hypoxic response by activating the asparaginyl hydroxylase FIH.
    Jin P; Kang J; Lee MK; Park JW
    Biochem Biophys Res Commun; 2018 May; 499(3):475-481. PubMed ID: 29580991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxylation of hypoxia-inducible transcription factors and chemical compounds targeting the HIF-alpha hydroxylases.
    Bruegge K; Jelkmann W; Metzen E
    Curr Med Chem; 2007; 14(17):1853-62. PubMed ID: 17627521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel drugs and the response to hypoxia: HIF stabilizers and prolyl hydroxylase.
    Nangaku M; Kojima I; Tanaka T; Ohse T; Kato H; Fujita T
    Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):129-39. PubMed ID: 18221080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.